Jubilant Pharmova Ltd.’s revenue in Q4FY23 rose 10% to ₹ 1,678 crores. Consolidated Loss After Tax came at ₹ 101 crores in
Jubilant Pharmova Q4FY23; Reported Losses
Categories
Radiopharma
Market Intelligence Ecosystem